Researchers at Hacettepe University Faculty of Medicine Release New Study Findings on COVID-19 (Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, ...)

Hamdi Levent Doğanay

Press/Media

Period	25 Nov 2022

Related content

Research output
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial
Research output: Contribution to journal › Article › peer-review